Marcus & Millichap Arranges the Sale of a Triple-Net Lease BioLife in Dallas, Texas
Senior Managing Directors, Austin Weisenbeck, and Sean R. Sharko, and Associate, Daniel Chumbley investment specialists in Marcus & Millichap’s Chicago Oak Brook office, had the exclusive listing to market the property on behalf of the seller, a limited liability company. The buyer, a private investment group, was secured and represented by Weisenbeck and Sharko. Tim Speck, Broker of Record of Texas, assisted in closing this transaction.
Situated at 875 W Central Texas Expy in Harker Heights, Texas, this 14,150-square-foot BioLife property stands prominently positioned conveniently off U.S. Highway 190, where a substantial flow of 53,619 vehicles per day passes. The property boasts a triple-net lease with 14 years remaining and a Takeda Pharmaceuticals guarantee.
The Sharko | Weisenbeck | Mendoza Group of Marcus & Millichap has sold over $3.60 billion in commercial real estate with well over 881 transactions in 35 states. In 2022, the SWM Group sold nearly $500 million in real estate through 101 transactions.
# # #
About Marcus & Millichap, Inc. (NYSE: MMI)
Marcus & Millichap, Inc. is a leading brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services with offices throughout the United States and Canada. As of December 31, 2022, the company had 1,904 investment sales and financing professionals in 81 offices who provide investment brokerage and financing services to sellers and buyers of commercial real estate. The company also offers market research, consulting and advisory services to clients. Marcus & Millichap closed 12,272 transactions in 2022, with a sales volume of approximately $86.3 billion. For additional information, please visit www.MarcusMillichap.com.